HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 2256

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  

CME Table of Contents   
Year : 2010  |  Volume : 35  |  Issue : 2  |  Page : 217-221

Censoring in clinical trials: Review of survival analysis techniques

1 London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
2 Department of Radiotherapy, Government Medical College, Chandigarh, India
3 Department of Community Medicine, Pt BDS PGIMS, Rohtak, Haryana, India

Date of Submission25-Apr-2009
Date of Acceptance25-Mar-2010
Date of Web Publication29-Jul-2010

Correspondence Address:
Shankar Prinja
G-427, GH-2, Sector 5, Mansa Devi Complex, Panchkula - 134 109, Haryana, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-0218.66859

Rights and Permissions


How to cite this article:
Prinja S, Gupta N, Verma R. Censoring in clinical trials: Review of survival analysis techniques. Indian J Community Med 2010;35:217-21

How to cite this URL:
Prinja S, Gupta N, Verma R. Censoring in clinical trials: Review of survival analysis techniques. Indian J Community Med [serial online] 2010 [cited 2022 Jul 6];35:217-21. Available from: https://www.ijcm.org.in/text.asp?2010/35/2/217/66859

   Introduction Top

Medical and epidemiological studies are mostly conducted with an interest in measuring the occurrence of an outcome event. Studies conducting survival analysis, however, are focussed toward measuring time to event or outcome. Time to event could vary from time to fatal event i.e. death, or time to occurrence of a clinical endpoint such as disease, or attainment of a biochemical marker. Survival analysis studies originated with the publication of John Graunt's Weekly Bills of Mortality in London. First life table was prepared by Healy. [1] Survival analysis is also known as lifetime data analysis, time to event analysis, reliability and event history analysis depending on focus and stream where it is used. However, survival analysis is plagued by problem of censoring in design of clinical trials which renders routine methods of determination of central tendency redundant in computation of average survival time. The present essay attempts to highlight different methods of survival analysis used to estimate time to event in studies based on individual patient level data in the presence of censoring. Section 2 highlights types of censoring encountered in a clinical trial, its types and potential statistical solutions. Survival analysis techniques, its assumptions and suitability of methods under different data conditions are illustrated in sections 3 and 4. The next section 5 discusses the importance of techniques to extrapolate estimate of life expectancy derived over a period of time exceeding the duration of trial follow-up. Lastly, section 6 cites limitations and advantages of different methods and finally concludes by indicating possible future areas of research and practice for health economists and public health professionals. We reviewed articles published in PubMed, Science Direct and Ovid search engines using "censoring in clinical trials", "survival analysis" and "Kaplan Meier method" as key words. After a total of 213 articles retrieved, articles focussing only on methodology aspect were considered for the present review. Original articles were preferred following by subsequent discussion articles, which added substantially to the methodology.

   Censoring in Clinical Trials Top

Censoring is said to be present when information on time to outcome event is not available for all study participants. Participant is said to be censored when information on time to event is not available due to loss to follow-up or non-occurrence of outcome event before the trial end. Broadly classifying two types of censoring are encountered, i.e. point and interval censoring. [2]

Point censoring is said to occur when despite continuous monitoring of outcome event, the patient is lost to follow-up or the event does not occur within the study duration. It is also known as right censoring which can be either end-of-study censoring or loss-to-follow-up censoring. An individual is said to be left censored if the patient had been on risk for disease for a period before entering the study. However, left censoring is usually not a problem in clinical trials, since starting point is defined by an event such as entry of patient in trial, randomization or occurrence of a procedure or treatment. Individuals B and C are right censored while individual F is left censored [Figure 1].

Problem of interval censoring arises when time to event may be known only up to a time interval. This situation occurs in case the assessment of monitoring is done at a periodical frequency. This is illustrated by a hypothetical study done to ascertain the incubation period of AIDS after occurrence of HIV infection [Figure 2]. Practically, most observational studies dealing with non-lethal outcomes have periodical examination schedules and are thus interval censored. However, if the periodicity of examination is at a justified frequency, interval censored data can be dealt with as point censored. [3]

Statisticians have devised various methods to deal with censored data which includes complete data analysis, imputation techniques or analysis based on dichotomized data. [2] However, these methods are laden with problems and complexities for others. Detailed discussion of each of these methods is beyond the scope of the present essay due to space constraint; however, it is important to bear in mind the techniques available. The more effective methods that are widely used in survival studies encountering censored data are likelihood-based approaches (survival analysis methods) which adjust for the occurrence of censoring in each observation, and thus are advantageous that it uses all available information.

   Survival Analysis Techniques Top

Survival analysis techniques used for dealing with censored data can be broadly classified into non-paramteric (Kaplan Meier product limit method), parametric (Weibull and exponential methods) and semi-paramteric method (Cox-proportional hazards method). The latter two can also be applied as regression-based models. However, usual likelihood-based functions of whole sample which are product of individual likelihood functions cannot be applied in the presence of complex censoring mechanisms, especially in the presence of both loss to follow-up and end of study censoring. In such situation, a joint distribution of survival and censoring times can be done. However, the distribution of survival time in such situation is considered as non-identifiable. Hence, the assumption of independent censoring is imperative. [2] This assumption implies that time to censoring and survival times are independent. In other words, censoring is independent of unusual high or low risk for occurrence of event which implies that survival times for censored and uncensored individuals is same and removal of censored individuals from analysis would yield an unbiased estimate of survival time or time to event.

   Non-Parametric Survival Analysis: Kaplan Meier Product Limit Method Top

This method computes the probability of dying at a certain point of time conditional to the survival up to that point. [4] It utilizes the information of censored individuals till the point when the patient is censored. Thus it maximizes utilization of available information on time to event of the study sample. The equation used to derive survival probability at time 't' is derived by the following equation:

where d t /n t represents the probability of dying at time 't' conditional to being at risk (alive) at 't-1' time.

The censored individuals are excluded from the denominator of 'at risk' individuals at the point when they are censored, however, are included at each preceding point. They are not included in numerator at any point. [Table 1] and [Table 2] illustrate a hypothetical dataset and computation of survival probability using the Kaplan Meier estimator, respectively.

Censoring affects the shape of survival curve in a situation when a large number of individuals are censored at a single point of time leading to sudden spurious large jumps or large flat section in survival curve. [5] Other factors leading to such spurious jump includes extremely low number of individuals at risk especially toward the end of the study or pre-arranged clinic visit schedule. Statistical significance of difference between two or more survival curves is determined by the log-rank test.

Reliability of the different portions of survival curve is dependent on the number of individuals at risk at that stage. Majority of studies dealing with analysis of survival time are likely to have some individuals for which outcome event and thus time to event or outcome is not recorded. This is in view of paucity of resources (money and time) to carry forward the study till outcomes (especially fatal outcomes) are recorded for each and every study individual. To have a measure of maturity of data thus becomes imperative to show quality of data in terms of adequacy of individuals for which outcome event and thus time to event is recorded. Simpler measures for maturity include average (median) follow-up period. However, a more robust graphical technique involves constructing a survival curve by reversing censoring i.e. labelling patients died as censored and vice-versa and computing time to follow-up for this dataset. Thus median time to follow-up is estimated using this technique which deals with censoring in the same manner as for time to survival. [5]

   Parametric Survival Analysis: Weibull and Exponential Methods Top

As in the non-parametric approaches in the analysis of time to event data, the models under parametric approach derive estimates of failure time statistics while accounting for the presence of censoring in the data. The main difference between the two approaches is that the latter attempt to derive estimates using a parametric model, which male specific assumptions about the distribution of failure time through assuming a particular functional form for the hazard rate. This functional form can specify the hazard rate as a function of time or can incorporate covariate information in which case the hazard rate is specified as a function of time and specific covariates. In this way, failure time is related to a set of covariates thus leading to a regression approach.

Parametric methods of survival analysis assume distribution of hazard rate as a function of time besides assumption of independent censoring. [5] Hazard rate is the instantaneous probability of dying in next short interval conditional upon having survived till time 't'. The expression d t /n t in Kaplan Meier product limit survival equation is hazard rate. The denominator n t includes total follow-up time till time 't' for both individuals who are at-risk and censored. Numerator d t is the number of individuals who die/ experience outcome event during the short time interval after 't'. Censoring plays a similar role in the models as in the case of the non-parametric hazard and the condition of independent censoring. The censoring is adjusted for in parametric models by incorporation of hazard rate which uses similar Kaplan Meier estimator. When the model incorporates covariates, the condition of independent censoring is assumed in the presence of covariates.

Weibull method assumes that hazard rate changes (increases or decreases) monotonically with time. Hazard rate and other parameters for Weibull distribution are shown in [Table 1]. Since hazard rate is time dependent, it increases for all values of P>1, decreases for p0 <1 and is constant for P=1 [Table 3].

Exponential distribution is a special case of Weibull distribution for which p0 =1, implying that the hazard rate does not vary with time. A constant value of hazard rate leads to a constant probability of dying, unchanged with passage of study duration or time. This highlights the fact that the probability of dying during any given interval is dependent only on the width of time interval, with directly proportional relationship. On the contrary, it is unaffected by the point of beginning and end of time interval.

It is important to ascertain the distribution of hazard rate for any dataset. Since the exponential distribution assumes constant hazard rate, this can be written as;

which can also be written as

Log [S(t)]= -λt or - Log [S(t)]= λt. Taking logarithms on each side,

Log{- Log [S(t)]}= logλ + log t

This is an equation of straight line, with slope 'b' equal to 1. Thus complementary log transformation i.e. Log{- Log [S(t)]}, against log t, is an effective tool for assessing constancy of hazard rate implying exponential distribution. [5]

   Semi-Parametric Survival Analysis Method: Cox-Proportional Hazard Method Top

The parametric models discussed above specify a specific form for the hazard function over time. As such these models fully characterize the distribution of failure time as a function of time (and covariates). If however, interest is primarily in determining how a new treatment affects survival compared to an old treatment, then a functional form for the hazard over time need not be specified. This leads to a semi-parametric regression models used to describe survival time in a comparative sense, the most commonly adopted of which is the Cox-proportional hazards model.

Cox-proportional hazard model is not a pure parametric method since it does not assume any functional form of distribution of hazard rate. However, it assumes that hazard function of any two individuals is proportional with the ratio being determined by the covariates that is constant over time. [6],[7] Clearly, if one is unsure of the functional form of hazard function, adopting a semi-parametric approach would be the preferred alternative to imposing specific parametric assumptions. Considering the semi-parametric assumption, the ratio of hazard functions for any two individuals is constant over time and is determined by the individuals' covariate values. The latter is nothing but an expression of relative risk.

The proportionality assumption of semi-parametric method can be assessed either graphically by plotting survival curves or by means of a test statistic, [8] dependent on which the null hypothesis is rejected if the p0 value is less than significance level. In graphic representation, proportionality assumption holds true if the two survival curves do not cross each other. Alternatively, complementary log transformation, Log{- Log [S(t)]}, is useful. Plot of the double log of two survival curves i.e. Log{- Log [S(1)]} and Log{- Log [S(2)]}is a straight line contingent to correctness of proportionality assumption.

Besides, the parametric and semi-parametric methods described above, rank regression methods have been used to deal with time to event data in the presence of censoring. Asymptotic normality of estimators is established under certain assumptions. This method makes use of martingale theory and a tightness lemma for stochastic integrals of multi-parameter empirical process. [9]

   Suitability of Survival Analysis Methods Top

Non-parametric methods i.e. Kaplan Meier product limit method and the Cox-proportional hazards model are the most commonly used methods for survival analysis in public health literature. Kaplan Meier method is suitable when no assumption about the functional distribution of hazard rate with time is made. However, since no assumption is made about hazard rate, no extrapolation of study results beyond the study period is possible. Parametric methods overcome this disadvantage and are used for extrapolation of study results beyond the study period discussed in subsequent section. Parametric and semi-parametric methods also help in ascertaining the influence of covariates on survival times. However, it is inappropriate to assume an exponential distribution universally, especially in case of survival rates following birth and survival rate after a major surgery, contingent upon knowledge that mortality rates are higher in infancy and in immediate post-operative period, respectively, with gradual decline thereafter. Semi-parametric methods can be useful in such situations. Cox-proportional method has the additional advantage of being able to ascertain influence of covariates such as demographic factors, nature of diseases and treatment received on hazard/survival rate.

An advantage of Cox-proportional hazard model over the log-rank test following Kaplan Meier method is the ability to use the former with continuous and categorical (after creation of dummy variable) variables. [5] On the other hand the log-rank test cannot deal with continuous variables.

   Extrapolation of Survival Estimates Beyond Study Follow-Up Top

Epidemiological studies estimating survival are generally conducted for a short follow-up period which is contingent upon recruitment of sufficient number of individuals to provide adequate study endpoints which powers the study to ascertain difference in influence of covariates on time to event at a given significance level. However, despite this relatively shorter follow-up, it is relevant in many cases to extrapolate results at longer time duration. This is especially pertinent in economic evaluations where time horizon has to be sufficiently large, in many cases life-time horizon, to guide decision-makers for making sound decisions. The above-mentioned statement particularly applies to preventive programs where benefits of a program start appearing and are yielded over longer time duration.

Extrapolation of results requires an assumption of how the present results would vary in course of time i.e. function of hazard rate over time. It may assume that the impact of covariate on hazard rate remains the same after the follow-up period; or it ceases to occur; or an intermediate situation. Alternatively a parametric method may be used to model observed data to extrapolate results. This is an application of Weibull and exponential methods. Lastly, survival curves from other observational studies are matched with present study data. Data from observational study which matches the present survival curve maximally is used to model the results beyond follow-up period.

   Conclusion Top

We acknowledge that this article does not cover in-depth certain finer points related to methods for survival analysis. Nonetheless, the article can serve as a good note for the beginners who are interested to learn survival analysis. The present essay discusses the role of survival analysis techniques in individual level patient data amidst censoring which have been widely used by health economists, public health professionals, social and behavioral scientists. Right censoring is primarily dealt with by the application of these survival analysis methods, while interval censoring has been dealt with by statisticians using imputation techniques. Left censoring is usually not a problem in thoughtfully designed clinical trials since starting point or beginning of risk period is defined by an event such as randomization or performance of an intervention.

Independence of censoring (or non-informative censoring) is the most important assumption in all methods. However, this assumption may also be null in situations termed as 'frailty' i.e. when time between two recurrent events (for instance repeated infections) is the measure of interest, some individuals may have higher chances or an unknown tendency to have recurrent events. [10]

Non-paramteric methods such as Kaplan Meier, Log Rank and Wilcoxon tests are the most commonly used methods for survival analysis. Improved versions with application of prognostic covariate information are being applied which make Kaplan Meier estimates much more robust in the presence of censoring. [11] Impact of covariates affecting the survival rates are commonly dealt with using Cox-proportional hazards method. Recent development of specialized softwares has generated greater interest in application of parametric methods which offer additional advantages and allow extrapolation of results beyond the study follow-up period.

   References Top

1.Lee ET, Go OT. Survival analysis in public health research. Annu Rev Public Health 1997;18:105-34.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Leung KM, Elashoff RM, Afifi AA. Censoring issues in survival analysis. Annu Rev Public Health 1997;18:83-104.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.de Gruttola V, Lagakos SW. Analysis of doubly censored survival data with application to AIDS. Biometrics 1989;45:1-11.  Back to cited text no. 3  [PUBMED]    
4.Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.  Back to cited text no. 4      
5.Machin D, Cheung YB, Parmar MK. Survival analysis a practical approach. 2 nd ed. West Sussex: John Wiley and Sons Ltd; 2006.  Back to cited text no. 5      
6.Cox DR. Regression models with life-tables (with discussion). J R Stat Soc Series B Stat Methodol 1972;34:269-76.  Back to cited text no. 6      
7.Breslow NE. Contribution to discussion of paper by DR Cox. J R Stat Soc Series B Stat Methodol 1972;34:216-7.  Back to cited text no. 7      
8.Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.  Back to cited text no. 8      
9.Lai L, Ying Z. Rank Regression Methods for left truncated and right censored data. Ann Stat 1991;19:531-6.  Back to cited text no. 9      
10.McGilchrist CA, Aisbett CW. Regression with frailty in survival analysis. Biometrics 1991;47:461-6.  Back to cited text no. 10  [PUBMED]    
11.Murray S, Tsiatis AA. Non-paramteric survival estimation using prognostic longitudinal covariates. Biometrics 1996;52:137-51.  Back to cited text no. 11  [PUBMED]    


  [Figure 1], [Figure 2]

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 CondiS: A conditional survival distribution-based method for censored data imputation overcoming the hurdle in machine learning-based survival analysis
Yizhuo Wang, Christopher R. Flowers, Ziyi Li, Xuelin Huang
Journal of Biomedical Informatics. 2022; : 104117
[Pubmed] | [DOI]
2 A New Survival Analysis Model in Adjuvant Tamoxifen-Treated Breast Cancer Patients Using Manifold-based Semi-Supervised Learning
Ramazan Teimouri Yansari, Mitra Mirzarezaee, Mehdi Sadeghi, Babak Nadjar Araabi
Journal of Computational Science. 2022; : 101645
[Pubmed] | [DOI]
3 Machine Learning vs. survival analysis models: a study on right censored heart failure data
B. Srujana, Dhananjay Verma, Sameen Naqvi
Communications in Statistics - Simulation and Computation. 2022; : 1
[Pubmed] | [DOI]
4 Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multice
Xiangwei Yang, Hong Chen, Duanya Xu, Xianju Chen, Yamei Li, Jun Tian, Dongwen Wang, Jun Pang
BMC Cancer. 2022; 22(1)
[Pubmed] | [DOI]
5 The importance of physical performance in the assessment of patients on haemodialysis: A survival analysis
Karsten Vanden Wyngaert, Wim Van Biesen, Sunny Eloot, Amaryllis H. Van Craenenbroeck, Patrick Calders, Els Holvoet, Melissa M. Markofski
PLOS ONE. 2022; 17(5): e0268115
[Pubmed] | [DOI]
6 High-Dimensional Mediation Analysis Based on Additive Hazards Model for Survival Data
Yidan Cui, Chengwen Luo, Linghao Luo, Zhangsheng Yu
Frontiers in Genetics. 2021; 12
[Pubmed] | [DOI]
7 Do specific delirium aetiologies have different associations with death? A longitudinal cohort of hospitalised patients
Louis A. Chalmers, Samuel D. Searle, Jon Whitby, Alex Tsui, Daniel Davis
European Geriatric Medicine. 2021; 12(4): 787
[Pubmed] | [DOI]
8 Cure models to estimate time until hospitalization due to COVID-19
Maria Pedrosa-Laza, Ana López-Cheda, Ricardo Cao
Applied Intelligence. 2021;
[Pubmed] | [DOI]
9 Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients
Ugo Sorrentino, Silvia Bellonzi, Chiara Mozzato, Valeria Brasson, Irene Toldo, Raffaele Parrozzani, Maurizio Clementi, Matteo Cassina, Eva Trevisson
Cancers. 2021; 13(24): 6336
[Pubmed] | [DOI]
10 Toward Data-Driven Learning Healthcare Systems in Interventional Radiology: Implementation to Evaluate Venous Stent Patency
David M. Cohn,Tarub S. Mabud,Victoria A. Arendt,Andre D. Souffrant,Gyeong S. Jeon,Xiao An,William T. Kuo,Daniel Y. Sze,Lawrence V. Hofmann,Daniel L. Rubin
Journal of Digital Imaging. 2020; 33(1): 25
[Pubmed] | [DOI]
11 Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials
Katherine Riester,Ludwig Kappos,Krzysztof Selmaj,Stacy Lindborg,Ilya Lipkovich,Jacob Elkins
Multiple Sclerosis and Related Disorders. 2020; 39: 101865
[Pubmed] | [DOI]
12 Time-to-event survival statistics in ophthalmology: Methodological research
Christopher J. Layton,Danielle M. Layton
Clinical & Experimental Ophthalmology. 2020; 48(9): 1136
[Pubmed] | [DOI]
13 Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective
Casey Quinn,Louis P Garrison,Anja K Pownell,Michael B Atkins,Gérard de Pouvourville,Kevin Harrington,Paolo Antonio Ascierto,Phil McEwan,Samuel Wagner,John Borrill,Elise Wu
Journal for ImmunoTherapy of Cancer. 2020; 8(2): e000648
[Pubmed] | [DOI]
14 Challenges of Integrative Disease Modeling in Alzheimeræs Disease
Sepehr Golriz Khatami,Christine Robinson,Colin Birkenbihl,Daniel Domingo-Fernández,Charles Tapley Hoyt,Martin Hofmann-Apitius
Frontiers in Molecular Biosciences. 2020; 6
[Pubmed] | [DOI]
15 Exploring the Effect of In-Game Purchases on Mobile Game Use with Smartphone Trace Data
Kristof Boghe,Laura Herrewijn,Frederik De Grove,Kyle Van Gaeveren,Lieven De Marez
Media and Communication. 2020; 8(3): 219
[Pubmed] | [DOI]
16 Prediction of running-induced Achilles tendinopathy with pain sensitivity – a 1-year prospective study
René B.K. Brund,Sten Rasmussen,Uwe G. Kersting,Lars Arendt-Nielsen,Thorvaldur Skuli Palsson
Scandinavian Journal of Pain. 2019; 19(1): 139
[Pubmed] | [DOI]
17 Labour characteristics of women achieving successful vaginal birth after caesarean section in three European countries
Susanne Grylka-Baeschlin,Mike Clarke,Cecily Begley,Deirdre Daly,Patricia Healy,Jane Nicoletti,Declan Devane,Sandra Morano,Gérard Krause,André Karch,Gerard Savage,Mechthild M. Gross
Midwifery. 2019; 74: 36
[Pubmed] | [DOI]
18 Masterful Meisters? Voluntary Certification and Quality in the German Crafts Sector
Kaja Fredriksen,Petrik Runst,Kilian Bizer
German Economic Review. 2019; 20(1): 83
[Pubmed] | [DOI]
19 Analysis of Potato Mop-Top Virus Survival Probability in Post-Harvest Storage
S. K. R. Yellareddygari,Owusu Domfeh,Francisco G. Bittara,Neil C. Gudmestad
American Journal of Potato Research. 2017; 94(6): 632
[Pubmed] | [DOI]
20 Meta-Analysis of the Effect of Obstructive Sleep Apnea on Cardiovascular Events After Percutaneous Coronary Intervention
Yingke Zhao,Branda Yee-Man Yu,Yanfei Liu,Yue Liu
The American Journal of Cardiology. 2017; 120(6): 1026
[Pubmed] | [DOI]
21 Research Pearls: The Significance of Statistics and Perils of Pooling. Part 2: Predictive Modeling
Erik Hohmann,Merrick J. Wetzler,Ralph B. DæAgostino
Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2017; 33(7): 1423
[Pubmed] | [DOI]
22 Medial shoe-ground pressure and specific running injuries: A 1-year prospective cohort study
René B.K. Brund,Sten Rasmussen,Rasmus O. Nielsen,Uwe G. Kersting,Uffe Laessoe,Michael Voigt
Journal of Science and Medicine in Sport. 2017; 20(9): 830
[Pubmed] | [DOI]
23 Estimating Dynamic Signals From Trial Data With Censored Values
Ali Yousefi,Darin D. Dougherty,Emad N. Eskandar,Alik S. Widge,Uri T. Eden
Computational Psychiatry. 2017; 1: 58
[Pubmed] | [DOI]
24 Feature selection through validation and un-censoring of endovascular repair survival data for predicting the risk of re-intervention
Omneya Attallah,Alan Karthikesalingam,Peter J. E. Holt,Matthew M. Thompson,Rob Sayers,Matthew J. Bown,Eddie C. Choke,Xianghong Ma
BMC Medical Informatics and Decision Making. 2017; 17(1)
[Pubmed] | [DOI]
25 Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status
Li-Ni Liu,Yung-Chang Lin,Christine Miaskowski,Shin-Cheh Chen,Mei-Ling Chen
BMC Cancer. 2017; 17(1)
[Pubmed] | [DOI]
26 Review of prostatic tumor using kaplan meier and cox regression
Ilker Etikan, Kabiru Bala, Ogunjesa Babatope, Ismail Bakir, Meliz Yuvali
Biometrics & Biostatistics International Journal. 2017; 6(5): 444
[Pubmed] | [DOI]
27 Machine learning and microsimulation techniques on the prognosis of dementia: A systematic literature review
Ana Luiza Dallora,Shahryar Eivazzadeh,Emilia Mendes,Johan Berglund,Peter Anderberg,Kewei Chen
PLOS ONE. 2017; 12(6): e0179804
[Pubmed] | [DOI]
28 Factors associated with the healing of complex surgical wounds in the breast and abdomen: retrospective cohort study
Eline Lima Borges,José Ferreira Pires Júnior,Mery Natali Silva Abreu,Vera Lúcia de Araújo Lima,Patrícia Aparecida Barbosa Silva,Sônia Maria Soares
Revista Latino-Americana de Enfermagem. 2016; 24(0)
[Pubmed] | [DOI]
29 Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review
Paramjit K Sandhu, Salma M A Musaad, Alan T Remaley, Stephanie S Buehler, Sonya Strider, James H Derzon, Hubert W Vesper, Anne Ranne, Colleen S Shaw, Robert H Christenson
The Journal of Applied Laboratory Medicine. 2016; 1(2): 214
[Pubmed] | [DOI]
30 Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives
Heinz G. Endres,Petra Kaufmann-Kolle,Valerie Steeb,Erik Bauer,Caroline Böttner,Petra Thürmann,Angelo Scuteri
PLOS ONE. 2016; 11(2): e0146811
[Pubmed] | [DOI]
31 The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
Matthew Warrender-Sparkes,Tim Spelman,Guillermo Izquierdo,Maria Trojano,Alessandra Lugaresi,François Grand’Maison,Eva Havrdova,Dana Horakova,Cavit Boz,Celia Oreja-Guevara,Raed Alroughani,Gerardo Iuliano,Pierre Duquette,Marc Girard,Murat Terzi,Raymond Hupperts,Pierre Grammond,Thor Petersen,Ricardo Fernandez-Bolaños,Marcela Fiol,Eugenio Pucci,Jeannette Lechner-Scott,Freek Verheul,Edgardo Cristiano,Vincent Van Pesch,Tatjana Petkovska-Boskova,Fraser Moore,Ilya Kister,Roberto Bergamaschi,Maria Laura Saladino,Mark Slee,Michael Barnett,Maria Pia Amato,Cameron Shaw,Neil Shuey,Carolyn Young,Orla Gray,Ludwig Kappos,Helmut Butzkueven,Tomas Kalincik,Vilija Jokubaitis
Multiple Sclerosis Journal. 2016; 22(4): 520
[Pubmed] | [DOI]
32 Quantifying intrinsic and extrinsic control of single-cell fates in cancer and stem/progenitor cell pedigrees with competing risks analysis
J. A. Cornwell,R. M. Hallett,S. Auf der Mauer,A. Motazedian,T. Schroeder,J. S. Draper,R. P. Harvey,R. E. Nordon
Scientific Reports. 2016; 6(1)
[Pubmed] | [DOI]
33 Cervical pessaries to prevent preterm birth in women with a multiple pregnancy: a per-protocol analysis of a randomized clinical trial
Sophie M.S. Liem,Ewoud Schuit,Mariëlle G. van Pampus,Marjo van Melick,Maurice Monfrance,Josje Langenveld,Ben W.J. Mol,Dick Bekedam
Acta Obstetricia et Gynecologica Scandinavica. 2016; 95(4): 444
[Pubmed] | [DOI]
34 Bayesian Perspective on Random Censored Survival Data
Chris B. Guure,Samuel Bosomprah
International Scholarly Research Notices. 2014; 2014: 1
[Pubmed] | [DOI]
35 result 1 Document Reinfection of Dogs with Fish-Borne Zoonotic Trematodes in Northern Vietnam following a Single Treatment with Praziquantel
Nissen, S., Nguyen, L.A.T., Thamsborg, S.M., Dalsgaard, A., Van Johansen, M.
Source of the Document PLoS Neglected Tropical Diseases. 2014;
36 Bayesian neural network approach for determining the risk of re-intervention after endovascular aortic aneurysm repair
Omneya Attallah,Xianghong Ma
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 2014; 228(9): 857
[Pubmed] | [DOI]
37 Reinfection of Dogs with Fish-Borne Zoonotic Trematodes in Northern Vietnam following a Single Treatment with Praziquantel
Sofie Nissen,Lan Anh Thi Nguyen,Stig Milan Thamsborg,Anders Dalsgaard,Maria Vang Johansen,Hector H. Garcia
PLoS Neglected Tropical Diseases. 2014; 8(1): e2625
[Pubmed] | [DOI]
38 Effective Attributes in Colorectal Cancer Relapse Using Artificial Neural Network and Cox Proportional Hazards Regression
Saeedeh Pourahmad,Bahareh Khosravi,Mohammad Mohamadianpanah
Annals of Colorectal Research. 2014; 2(2)
[Pubmed] | [DOI]


Print this article  Email this article


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Article in PDF (365 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Censoring in Cli...
    Survival Analysi...
    Non-Parametric S...
    Parametric Survi...
    Semi-Parametric ...
    Suitability of S...
    Extrapolation of...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded2172    
    Comments [Add]    
    Cited by others 38    

Recommend this journal

  Sitemap | What's New | Copyright and Disclaimer | Privacy Notice
  © 2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007